Internal Medicine, Hematology & Oncology · Westbrook, ME
NPI
1487651584
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11 Rock Row Ste 120
Westbrook, ME, 04092
Phone (207) 303-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
154,747 services
Medicare patients, 2024
492
Average age 75
Drug cost, 2024
$12.8M
2,379 prescriptions
Company payments, 2025
$570
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christian A Thomas was code J1439 (injection, ferric carboxymaltose, 1 mg), 38,250 times for 28 patients. In total Christian A Thomas billed 154,747 services in 189 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 38,250 | 28 | $0.88 | $34K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,400 | 22 | $44.59 | $731K |
| J0897 Injection, denosumab, 1 mg | Office | 7,800 | 38 | $20.75 | $162K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,376 | 13 | $20.98 | $50K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,880 | 13 | $35.41 | $67K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,760 | 59 | $0.09 | $157 |
| 85025 Blood Count | Office | 1,308 | 383 | $7.59 | $9,932 |
| 80053 Clinical Chemistry | Office | 1,294 | 377 | $10.33 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,179 | 340 | $8.64 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 810 | 38 | $0.26 | $211 |
| 99214 Office E&M - Established | Office | 745 | 245 | $100.03 | $75K |
| 84153 Clinical Chemistry | Office | 530 | 136 | $18.02 | $9,551 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 480 | 68 | $139.53 | $67K |
| 96413 Chemotherapy Administration | Office | 352 | 112 | $107.00 | $38K |
| 96375 Injection Administration | Office | 345 | 90 | $12.78 | $4,408 |
By year: 2022 $3.2M for 151,769 services; 2023 $2.8M for 143,746 services; 2024 $3.2M for 154,747 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,308 | 383 | $7.59 | $9,932 |
| 80053 Clinical Chemistry | 1,294 | 377 | $10.33 | $13K |
| 36415 Venipuncture Blood Collection | 1,179 | 340 | $8.64 | $10K |
| 84153 Clinical Chemistry | 530 | 136 | $18.02 | $9,551 |
| 84443 Clinical Chemistry | 137 | 56 | $16.46 | $2,255 |
| 83735 Clinical Chemistry | 102 | 52 | $6.57 | $670 |
| 83550 Clinical Chemistry | 87 | 54 | $8.57 | $746 |
| 83540 Clinical Chemistry | 87 | 54 | $6.34 | $552 |
| 82728 Clinical Chemistry | 86 | 52 | $13.36 | $1,149 |
| 84439 Clinical Chemistry | 67 | 21 | $8.84 | $592 |
Medicare prescription drug claims, 2024
In 2024, the drug Christian A Thomas prescribed most often to Medicare patients was Abiraterone Acetate, with 454 prescriptions and refills. In total Christian A Thomas wrote 2,379 Medicare prescriptions that cost $12.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 454 | 462 | 70 | $1.1M |
| Orgovyx Relugolix | 269 | 272 | 28 | $730K |
| Nubeqa Darolutamide | 234 | 238 | 38 | $3.2M |
| Prednisone Generic | 228 | 255 | 49 | $1,034 |
| Erleada Apalutamide | 146 | 155 | 19 | $2.1M |
| Eligard Leuprolide Acetate | 128 | 371 | 40 | $169K |
| Xtandi Enzalutamide | 116 | 116 | 19 | $1.6M |
| Cabometyx Cabozantinib S-Malate | 69 | 69 | Under 11 | $1.6M |
| Levothyroxine Sodium Generic | 59 | 80 | 14 | $296 |
| Lupron Depot Leuprolide Acetate | 52 | 160 | 21 | $328K |
| Bicalutamide Generic | 50 | 70 | 18 | $915 |
| Gabapentin Generic | 42 | 76 | 16 | $295 |
| Potassium Chloride Generic | 33 | 45 | 12 | $271 |
| Everolimus Generic | 23 | 23 | Under 11 | $53K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 21 | 24 | Under 11 | $157 |
Brand drugs: 1,159 claims; generic drugs: 1,220 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christian A Thomas $570 ($570 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $102.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $102 |
| Daiichi Sankyo Inc. 4568.T | 4 | $87.96 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $56.23 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $47.69 |
| Pfizer Inc. PFE | 2 | $39.4 |
| Merck Sharp & Dohme LLC MRK | 2 | $37.17 |
| Genzyme Corporation SNY | 1 | $34.02 |
| Janssen Biotech, Inc. JNJ | 1 | $33.7 |
| Astellas Pharma US Inc 4503.T | 1 | $29.46 |
| Incyte Corporation INCY | 1 | $24.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.